Share dilution from the exercise of stock options
First written in FY2016. 17 of 19 entries say "Materialised", first in FY2020-Q1. Latest entry: FY2025.
The whole theme swung hardest in 2017: 37 of 68 companies on the "Worse" side.
- FY2025MaterialisedAnnual report
「1 July 2024–30 June 2025” “324,800” “The increase resulted from the exercise of stock acquisition rights.」
In FY2025, the number of issued shares increased by 324,800 through the exercise of stock acquisition rights, and exercises resulting in share dilution continued. - FY2025-H1MaterialisedAnnual report
「1 July 2024–31 December 2024 (Note) 1 110,000 635,138,540 51 23,589 51 24,895 (Note) 1. The increase resulted from the exercise of stock acquisition rights.」
During the interim consolidated accounting period, the exercise of stock acquisition rights increased the number of issued shares by 110,000, followed by a further increase of 9,600 in January 2025. - FY2024MaterialisedAnnual report
「The increase of 362 thousand in the total number of issued common shares resulted from the exercise of stock options.」
In FY2024, the exercise of stock options increased the number of issued shares by 362 thousand, with exercises resulting in dilution continuing. - FY2024-Q3MaterialisedAnnual report
「76,800 634,905,740 36 23,480 36 24,787 The exercise of stock acquisition rights increased the number of issued shares by 43,200 between 1 April 2024 and 30 April 2024, and increased capital and the capital reserve by ¥20 million each.」
The exercise of stock acquisition rights increased the number of issued shares by 76,800 during the third quarter and by a further 43,200 before the filing date, with exercises resulting in dilution continuing. - FY2024-Q1MaterialisedAnnual report
「1 July 2023–30 September 2023 (Note) 1 68,000 634,734,240 32 23,383 32 24,690 The increase resulted from the exercise of stock acquisition rights. In addition, between 1 October 2023 and 31 October 2023, the exercise of stock acquisition rights increased the total number of issued shares by 26,000 and capital and the capital reserve by ¥12 million each.」
The exercise of stock acquisition rights increased the number of issued shares by 68,000 during the first quarter and by a further 26,000 before the filing date, with exercises resulting in share dilution continuing. - FY2023MaterialisedAnnual report
「The increase of 288 thousand in the total number of issued common shares resulted from the exercise of stock options.」
In FY2023, the exercise of stock options increased the number of issued shares by approximately 288 thousand, with exercises resulting in dilution continuing. - FY2023-Q3MaterialisedAnnual report
「The increase resulted from the exercise of stock acquisition rights. In addition, between 1 April 2023 and 30 April 2023, the exercise of stock acquisition rights increased the total number of issued shares by 19,600, capital by ¥9 million and the capital reserve by ¥9 million.」
The exercise of stock acquisition rights increased the number of issued shares by 99,200 during the third quarter and by a further 19,600 before the filing date, with exercises resulting in dilution continuing. - FY2023-Q2MaterialisedAnnual report
「The increase resulted from the exercise of share acquisition rights.」
The exercise of stock acquisition rights increased the total number of issued shares by 67,600 during the second quarter and by a further 23,600 before the filing date. In addition, the company issued the second paid stock option covering 3,705,300 common shares. - FY2022-Q2MaterialisedAnnual report
「1 October 2021–31 December 2021” “31,600” “The increase resulted from the exercise of stock acquisition rights.」
The exercise of stock acquisition rights increased the total number of issued shares by 31,600 during the second quarter, with exercises resulting in share dilution continuing. - FY2022-Q1MaterialisedAnnual report
「1 July 2021–30 September 2021 50,400 634,289,840 23 23,176 23 24,483” “The increase resulted from the exercise of stock acquisition rights.」
The exercise of stock acquisition rights increased the total number of issued shares by 50,400 during the first quarter, with exercises resulting in share dilution continuing. - FY2021MaterialisedAnnual report
「1 July 2020–30 June 2021” “310,400” “The increase resulted from the exercise of stock acquisition rights.」
The exercise of stock acquisition rights increased the total number of issued shares by 310,400 during the consolidated fiscal year, with exercises resulting in dilution continuing. - FY2021-Q3MaterialisedAnnual report
「The increase resulted from the exercise of stock acquisition rights. In addition, between 1 April 2021 and 30 April 2021, the exercise of stock acquisition rights increased the total number of issued shares by 19,200, capital by ¥9 million and the capital reserve by ¥9 million.」
The exercise of stock acquisition rights increased the total number of issued shares by 91,600 during the third quarter and by a further 19,200 before the filing date, with exercises resulting in dilution continuing. - FY2021-Q2MaterialisedAnnual report
「1 July 2020–31 December 2020” “54,400” “1. The increase resulted from the exercise of stock acquisition rights.」
The exercise of stock acquisition rights increased the total number of issued shares by 54,400 during the second quarter, with exercises resulting in share dilution continuing. - FY2021-Q1MaterialisedAnnual report
「The increase resulted from the exercise of share acquisition rights.」
The exercise of stock acquisition rights increased the total number of issued shares by 122,000 during the first quarter and by a further 12,800 before the filing date, with exercises resulting in share dilution continuing. - FY2020-Q3MaterialisedAnnual report
「The increase resulted from the exercise of stock acquisition rights. In addition, between 1 April 2020 and 30 April 2020, the exercise of stock acquisition rights increased the total number of issued shares by 6,400, capital by ¥3 million and the capital reserve by ¥3 million.」
The exercise of stock acquisition rights increased the number of issued shares by 120,400 during the third quarter and by a further 6,400 before the filing date, with exercises resulting in dilution continuing. - FY2020-Q2MaterialisedAnnual report
「The increase resulted from the exercise of stock acquisition rights. In addition, between 1 January 2020 and 31 January 2020, the exercise of stock acquisition rights increased the total number of issued shares by 54,400, capital by ¥25 million and the capital reserve by ¥25 million.」
The exercise of stock acquisition rights increased the number of issued shares by 194,800 during the quarter and by a further 54,400 before the filing date. - FY2020-Q1MaterialisedAnnual report
「The increase resulted from the exercise of share acquisition rights.」
The exercise of stock acquisition rights increased the number of issued shares by a total of 200,900 during the quarter and by a further 114,000 before the filing date, demonstrating continued exercises that resulted in share dilution. - FY2017RestatedAnnual report
「In addition to the stock options currently granted, the exercise of stock acquisition rights to be granted in the future may dilute the company's shares.」
This reiterates the risk of share dilution from the exercise of stock options. - FY2016First statedAnnual report
「In addition to the stock options currently granted, the exercise of stock acquisition rights to be granted in the future may dilute the company's shares.」
The disclosure describes the issuance of stock acquisition rights for 969,700 shares, including stock acquisition rights subject to performance conditions.